tradingkey.logo

Merck & Co Inc

MRK
91.410USD
+0.460+0.51%
Giờ giao dịch ETBáo giá bị trễ 15 phút
227.37BVốn hóa
11.95P/E TTM

Merck & Co Inc

91.410
+0.460+0.51%

Thêm thông tin về Merck & Co Inc Công ty

Merck & Co., Inc. is a research-intensive biopharmaceutical company engaged in research to deliver health solutions that advance the prevention and treatment of diseases in people and animals. Its Pharmaceutical segment includes human health pharmaceutical and vaccine products. Human health pharmaceutical products consist of therapeutic and preventive agents, generally sold by prescription, for the treatment of human disorders. Human health vaccine products consist of preventive pediatric, adolescent and adult vaccines. The Animal Health segment discovers, develops, manufactures and markets a range of veterinary pharmaceutical and vaccine products, as well as health management solutions and services, for the prevention, treatment and control of disease in all major livestock and companion animal species. It is also engaged in developed a novel class of small molecules that target cancer cells lacking expression of a key DNA repair protein called O6-methylguanine methyl transferase.

Thông tin của Merck & Co Inc

Mã chứng khoánMRK
Tên công tyMerck & Co Inc
Ngày IPOJan 01, 1941
Giám đốc điều hànhMr. Robert M. (Rob) Davis
Số lượng nhân viên75000
Loại chứng khoánOrdinary Share
Kết thúc năm tài chínhJan 01
Địa chỉ126 East Lincoln Avenue
Thành phốRAHWAY
Sàn giao dịch chứng khoánNYSE Consolidated
Quốc giaUnited States of America
Mã bưu điện07065
Điện thoại19087404000
Trang webhttps://www.merck.com/
Mã chứng khoánMRK
Ngày IPOJan 01, 1941
Giám đốc điều hànhMr. Robert M. (Rob) Davis

Lãnh đạo công ty của Merck & Co Inc

Tên
Tên/Chức vụ
Chức vụ
Tỷ lệ sở hữu cổ phần
Thay đổi
Mr. Robert M. (Rob) Davis
Mr. Robert M. (Rob) Davis
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
443.60K
--
Mr. Sanat Chattopadhyay
Mr. Sanat Chattopadhyay
Executive Vice President and President - Merck Manufacturing Division
Executive Vice President and President - Merck Manufacturing Division
185.33K
+17.90%
Mr. Chirfi Guindo
Mr. Chirfi Guindo
Senior Vice President, Chief Marketing Officer - Human Health
Senior Vice President, Chief Marketing Officer - Human Health
85.34K
+28.11%
Dr. Dean Y. Li, M.D., Ph.D.
Dr. Dean Y. Li, M.D., Ph.D.
Executive Vice President, President - Merck Research Laboratories
Executive Vice President, President - Merck Research Laboratories
79.59K
+0.92%
Ms. Jennifer L. Zachary
Ms. Jennifer L. Zachary
Executive Vice President, General Counsel
Executive Vice President, General Counsel
53.42K
+90.81%
Mr. Joseph Edward Romanelli
Mr. Joseph Edward Romanelli
Senior Vice President, President - MSD International Human Health
Senior Vice President, President - MSD International Human Health
22.91K
+5.27%
Ms. Patricia F. Russo
Ms. Patricia F. Russo
Independent Director
Independent Director
13.15K
--
Mr. Thomas Henry (Tom) Glocer, J.D.
Mr. Thomas Henry (Tom) Glocer, J.D.
Lead Independent Director
Lead Independent Director
5.10K
--
Mr. Inge G. Thulin
Mr. Inge G. Thulin
Independent Director
Independent Director
2.93K
--
Ms. Pamela J. Craig
Ms. Pamela J. Craig
Independent Director
Independent Director
1.72K
--
Xem thêm
Tên
Tên/Chức vụ
Chức vụ
Tỷ lệ sở hữu cổ phần
Thay đổi
Mr. Robert M. (Rob) Davis
Mr. Robert M. (Rob) Davis
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
443.60K
--
Mr. Sanat Chattopadhyay
Mr. Sanat Chattopadhyay
Executive Vice President and President - Merck Manufacturing Division
Executive Vice President and President - Merck Manufacturing Division
185.33K
+17.90%
Mr. Chirfi Guindo
Mr. Chirfi Guindo
Senior Vice President, Chief Marketing Officer - Human Health
Senior Vice President, Chief Marketing Officer - Human Health
85.34K
+28.11%
Dr. Dean Y. Li, M.D., Ph.D.
Dr. Dean Y. Li, M.D., Ph.D.
Executive Vice President, President - Merck Research Laboratories
Executive Vice President, President - Merck Research Laboratories
79.59K
+0.92%
Ms. Jennifer L. Zachary
Ms. Jennifer L. Zachary
Executive Vice President, General Counsel
Executive Vice President, General Counsel
53.42K
+90.81%
Mr. Joseph Edward Romanelli
Mr. Joseph Edward Romanelli
Senior Vice President, President - MSD International Human Health
Senior Vice President, President - MSD International Human Health
22.91K
+5.27%

Phân tích doanh thu

Tiền tệ: USDThời gian cập nhật: T2, 6 Th10
Tiền tệ: USDThời gian cập nhật: T2, 6 Th10
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
Theo Doanh nghiệpUSD
Tên
Doanh thu
Tỷ trọng
Oncology-Keytruda
7.96B
50.34%
Vaccines -Gardasil/Gardasil
1.13B
7.12%
Animal Health-Livestock
961.00M
6.08%
Animal Health-Companion Animals
685.00M
4.33%
Vaccines -ProQuad/M-M-R II/Varivax
609.00M
3.85%
Khác
4.47B
28.27%
Theo Khu vựcUSD
Tên
Doanh thu
Tỷ trọng
United States
8.84B
55.90%
Europe, Middle East and Africa
3.66B
23.15%
Latin America
859.00M
5.43%
Asia Pacific (Other than China and Japan)
785.00M
4.97%
Japan
626.00M
3.96%
Khác
1.04B
6.59%
Theo Doanh nghiệp
Theo Khu vực
Theo Doanh nghiệpUSD
Tên
Doanh thu
Tỷ trọng
Oncology-Keytruda
7.96B
50.34%
Vaccines -Gardasil/Gardasil
1.13B
7.12%
Animal Health-Livestock
961.00M
6.08%
Animal Health-Companion Animals
685.00M
4.33%
Vaccines -ProQuad/M-M-R II/Varivax
609.00M
3.85%
Khác
4.47B
28.27%

Thống kê Cổ phần

Thời gian cập nhật: T3, 19 Th08
Thời gian cập nhật: T3, 19 Th08
Cổ đông
Loại Cổ đông
Cổ đông
Cổ đông
Tỷ trọng
The Vanguard Group, Inc.
10.11%
BlackRock Institutional Trust Company, N.A.
5.75%
State Street Investment Management (US)
4.77%
Wellington Management Company, LLP
3.10%
Geode Capital Management, L.L.C.
2.38%
Khác
73.89%
Cổ đông
Cổ đông
Tỷ trọng
The Vanguard Group, Inc.
10.11%
BlackRock Institutional Trust Company, N.A.
5.75%
State Street Investment Management (US)
4.77%
Wellington Management Company, LLP
3.10%
Geode Capital Management, L.L.C.
2.38%
Khác
73.89%
Loại Cổ đông
Cổ đông
Tỷ trọng
Investment Advisor
42.29%
Investment Advisor/Hedge Fund
27.29%
Research Firm
3.21%
Pension Fund
2.47%
Bank and Trust
2.34%
Sovereign Wealth Fund
1.56%
Hedge Fund
1.38%
Insurance Company
0.71%
Family Office
0.12%
Khác
18.62%

Cổ phần của tổ chức

Thời gian cập nhật: T4, 1 Th10
Thời gian cập nhật: T4, 1 Th10
Chu kỳ Báo cáo
Số lượng tổ chức
Cổ phiếu nắm giữ
Tỷ trọng
Thay đổi
2025Q3
5358
2.02B
81.35%
-45.75M
2025Q2
5398
2.02B
80.82%
-16.42M
2025Q1
5446
2.05B
81.47%
-3.32M
2024Q4
5410
2.04B
80.88%
+11.87M
2024Q3
5200
2.01B
79.47%
-7.96M
2024Q2
5181
2.01B
79.28%
-4.86M
2024Q1
5154
2.00B
78.88%
-6.10M
2023Q4
5065
1.99B
78.60%
+584.81K
2023Q3
4871
1.98B
78.17%
-32.03M
2023Q2
4864
2.00B
78.94%
-18.54M
Xem thêm

Hoạt động của Cổ đông

Tên
Cổ phiếu nắm giữ
Tỷ trọng
Thay đổi
Thay đổi %
Ngày
The Vanguard Group, Inc.
251.75M
10.08%
+356.59K
+0.14%
Jun 30, 2025
BlackRock Institutional Trust Company, N.A.
142.78M
5.72%
-4.51M
-3.06%
Jun 30, 2025
State Street Investment Management (US)
118.49M
4.74%
-2.04M
-1.69%
Jun 30, 2025
Wellington Management Company, LLP
76.86M
3.08%
-4.81M
-5.89%
Jun 30, 2025
Geode Capital Management, L.L.C.
58.95M
2.36%
-704.59K
-1.18%
Jun 30, 2025
Charles Schwab Investment Management, Inc.
53.87M
2.16%
+4.64M
+9.42%
Jun 30, 2025
Norges Bank Investment Management (NBIM)
36.11M
1.45%
+1.13M
+3.23%
Jun 30, 2025
Fidelity Management & Research Company LLC
28.48M
1.14%
+229.47K
+0.81%
Jun 30, 2025
Fisher Investments
25.01M
1%
+567.90K
+2.32%
Jun 30, 2025
BlackRock Asset Management Ireland Limited
22.79M
0.91%
+764.14K
+3.47%
Jun 30, 2025
Xem thêm

ETF liên quan

Thời gian cập nhật: T5, 6 Th11
Thời gian cập nhật: T5, 6 Th11
Tên
Tỷ trọng
FT Vest DJIA Dogs 10 Target Income ETF
7.58%
VanEck Pharmaceutical ETF
7.44%
First Trust NASDAQ Pharmaceuticals ETF
7.32%
Coastal Compass 100 ETF
7.15%
Invesco Dow Jones Industrial Average Dividend ETF
6.85%
iShares ESG Aware MSCI USA Value ETF
5.44%
First Trust Morningstar Dividend Leaders Index Fund
5.03%
Franklin Income Focus ETF
4.92%
Invesco Pharmaceuticals ETF
4.84%
VanEck Morningstar Wide Moat Value ETF
4.6%
Xem thêm
FT Vest DJIA Dogs 10 Target Income ETF
Tỷ trọng7.58%
VanEck Pharmaceutical ETF
Tỷ trọng7.44%
First Trust NASDAQ Pharmaceuticals ETF
Tỷ trọng7.32%
Coastal Compass 100 ETF
Tỷ trọng7.15%
Invesco Dow Jones Industrial Average Dividend ETF
Tỷ trọng6.85%
iShares ESG Aware MSCI USA Value ETF
Tỷ trọng5.44%
First Trust Morningstar Dividend Leaders Index Fund
Tỷ trọng5.03%
Franklin Income Focus ETF
Tỷ trọng4.92%
Invesco Pharmaceuticals ETF
Tỷ trọng4.84%
VanEck Morningstar Wide Moat Value ETF
Tỷ trọng4.6%

Cổ tức

Tổng cộng 35.12B USD đã được phân phối dưới dạng cổ tức trong 5 năm qua.
Ngày
Cổ tức
Ngày ghi sổ
Ngày thanh toán
Ngày không hưởng cổ tức
Jan 28, 2025
MRK.NB Interim Cash Dividend of gross USD 0.81 paid on Apr 07, 2025 going ex on Mar 17, 2025
Mar 17, 2025
Apr 07, 2025
Mar 17, 2025
Nov 19, 2024
MRK.NB Final Cash Dividend of gross USD 0.81 paid on Jan 08, 2025 going ex on Dec 16, 2024
Dec 16, 2024
Jan 08, 2025
Dec 16, 2024
Jul 23, 2024
MRK.NB Interim Cash Dividend of gross USD 0.77 paid on Oct 07, 2024 going ex on Sep 16, 2024
Sep 16, 2024
Oct 07, 2024
Sep 16, 2024
May 29, 2024
MRK.NB Interim Cash Dividend of gross USD 0.77 paid on Jul 08, 2024 going ex on Jun 17, 2024
Jun 17, 2024
Jul 08, 2024
Jun 17, 2024
Jan 23, 2024
MRK.NB Interim Cash Dividend of gross USD 0.77 paid on Apr 05, 2024 going ex on Mar 14, 2024
Mar 15, 2024
Apr 05, 2024
Mar 14, 2024
Nov 28, 2023
MRK.NB Final Cash Dividend of gross USD 0.77 paid on Jan 08, 2024 going ex on Dec 14, 2023
Dec 15, 2023
Jan 08, 2024
Dec 14, 2023
Jul 25, 2023
MRK.NB Interim Cash Dividend of gross USD 0.73 paid on Oct 06, 2023 going ex on Sep 14, 2023
Sep 15, 2023
Oct 06, 2023
Sep 14, 2023
May 23, 2023
MRK.NB Interim Cash Dividend of gross USD 0.73 paid on Jul 10, 2023 going ex on Jun 14, 2023
Jun 15, 2023
Jul 10, 2023
Jun 14, 2023
Jan 24, 2023
MRK.NB Interim Cash Dividend of gross USD 0.73 paid on Apr 10, 2023 going ex on Mar 14, 2023
Mar 15, 2023
Apr 10, 2023
Mar 14, 2023
Nov 30, 2022
MRK.NB Final Cash Dividend of gross USD 0.73 paid on Jan 09, 2023 going ex on Dec 14, 2022
Dec 15, 2022
Jan 09, 2023
Dec 14, 2022
Xem thêm

Chia tách cổ phiếu

Ngày
Loại
Tỷ lệ
Không có dữ liệu
Ngày
Loại
Tỷ lệ
Không có dữ liệu
KeyAI